Literature DB >> 15763544

Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine.

Andres A Caro1, Arthur I Cederbaum.   

Abstract

The objective of this work was to evaluate the possible in vitro interactions of S-adenosyl-l-methionine (SAM) and its metabolites S-(5'-Adenosyl)-l-homocysteine (SAH), 5'-Deoxy-5'-(methylthio)adenosine (MTA) and methionine with cytochrome P450 enzymes, in particular CYP2E1. SAM (but not SAH, MTA or methionine) produced a type II binding spectrum with liver microsomal cytochrome P450 from rats treated with acetone or isoniazid to induce CYP2E1. Binding was less effective for control microsomes. SAM did not alter the carbon monoxide binding spectrum of P450, nor denature P450 to P420, nor inhibit the activity of NADPH-P450 reductase. However, SAM inhibited the catalytic activity of CYP2E1 with typical substrates such as p-nitrophenol, ethanol, and dimethylnitrosamine, with an IC(50) around 1.5-5mM. SAM was a non-competitive inhibitor of CYP2E1 catalytic activity and its inhibitory actions could not be mimicked by methionine, SAH or MTA. However, SAM did not inhibit the oxidation of ethanol to alpha-hydroxyethyl radical, an assay for hydroxyl radical generation. In microsomes engineered to express individual human P450s, SAM produced a type II binding spectrum with CYP2E1-, but not with CYP3A4-expressing microsomes, and SAM was a weaker inhibitor against the metabolism of a specific CYP3A4 substrate than a specific CYP2E1 substrate. SAM also inhibited CYP2E1 catalytic activity in intact HepG2 cells engineered to express CYP2E1. These results suggest that SAM interacts with cytochrome P450s, especially CYP2E1, and inhibits the catalytic activity of CYP2E1 in a reversible and non competitive manner. However, SAM is a weak inhibitor of CYP2E1. Since the K(i) for SAM inhibition of CYP2E1 activity is relatively high, inhibition of CYP2E1 activity is not likely to play a major role in the ability of SAM to protect against the hepatotoxicity produced by toxins requiring metabolic activation by CYP2E1 such as acetaminophen, ethanol, carbon tetrachloride, thioacetamide and carcinogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763544     DOI: 10.1016/j.bcp.2005.01.007

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Novel protective mechanisms for S-adenosyl-L-methionine against acetaminophen hepatotoxicity: improvement of key antioxidant enzymatic function.

Authors:  James Michael Brown; John G Ball; Michael Scott Wright; Stephanie Van Meter; Monica A Valentovic
Journal:  Toxicol Lett       Date:  2012-06-05       Impact factor: 4.372

Review 2.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Total (bio)synthesis: strategies of nature and of chemists.

Authors:  Alexandra A Roberts; Katherine S Ryan; Bradley S Moore; Tobias A M Gulder
Journal:  Top Curr Chem       Date:  2010

4.  Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress.

Authors:  Andres A Caro; Alanna Davis; Sydney Fobare; Nicholas Horan; Cameron Ryan; Cara Schwab
Journal:  Toxicol In Vitro       Date:  2018-09-06       Impact factor: 3.500

5.  Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.

Authors:  Marta Varela-Rey; Nuria Martínez-López; David Fernández-Ramos; Nieves Embade; Diego F Calvisi; Aswhin Woodhoo; Juan Rodríguez; Mario F Fraga; Josep Julve; Elisabeth Rodríguez-Millán; Itziar Frades; Luís Torres; Zigmund Luka; Conrad Wagner; Manel Esteller; Shelly C Lu; M Luz Martínez-Chantar; José M Mato
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.

Authors:  Phillip H Hwang; Lisa Lian; Athanasios I Zavras
Journal:  Med Hypotheses       Date:  2011-11-17       Impact factor: 1.538

7.  Mechanism for prevention of alcohol-induced liver injury by dietary methyl donors.

Authors:  Christine L Powell; Blair U Bradford; Christopher Patrick Craig; Masato Tsuchiya; Takeki Uehara; Thomas M O'Connell; Igor P Pogribny; Stepan Melnyk; Dennis R Koop; Lisa Bleyle; David W Threadgill; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2010-01-29       Impact factor: 4.849

Review 8.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

9.  A decrease in S-adenosyl-L-methionine potentiates arachidonic acid cytotoxicity in primary rat hepatocytes enriched in CYP2E1.

Authors:  Jian Zhuge
Journal:  Mol Cell Biochem       Date:  2008-04-15       Impact factor: 3.396

10.  Depletion of S-adenosyl-l-methionine with cycloleucine potentiates cytochrome P450 2E1 toxicity in primary rat hepatocytes.

Authors:  Jian Zhuge; Arthur I Cederbaum
Journal:  Arch Biochem Biophys       Date:  2007-06-15       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.